Predictors of adherence to nicotine replacement therapy: Machine learning evidence that perceived need predicts medication use

• Published in: Drug and alcohol dependence 2019-12, Vol.205, p.107668-107668, Article 107668
• Main Authors: Kim, Nayoung, McCarthy, Danielle E., Loh, Wei-Yin, Cook, Jessica W., Piper, Megan E., Schlam, Tanya R., Baker, Timothy B.
• Format: Article
• Language: English
• Subjects: Adherence; Adherents; Cigarette smoking; Classification; Classification tree; Clinical trials; Counseling; Dependence; Drug addiction; Drug dependence; Drugs; Learning algorithms; Machine learning; Motivation; Nicotine; Nicotine dependence; Nicotine replacement therapy; Reactivity; Reminders; Smoking; Smoking cessation; Subgroups; Therapy; Transdermal medication
• ISSN: 0376-8716; 1879-0046
• DOI: 10.1016/j.drugalcdep.2019.107668

•Classification trees identified smokers high vs. low in adherence to medication.•Nicotine dependence, quitting motivation, and smoking triggers predicted adherence.•Negative beliefs about nicotine medication predicted nonadherence. Nonadherence to smoking cessation medication is a frequent problem. Identifying pre-quit predictors of nonadherence may help explain nonadherence and suggest tailored interventions to address it. Identify and characterize subgroups of smokers based on adherence to nicotine replacement therapy (NRT). Secondary classification tree analyses of data from a 2-arm randomized controlled trial of Recommended Usual Care (R-UC, n = 315) versus Abstinence-Optimized Treatment (A-OT, n = 308) were conducted. R-UC comprised 8 weeks of nicotine patch plus brief counseling whereas A-OT comprised 3 weeks of pre-quit mini-lozenges, 26 weeks of nicotine patch plus mini-lozenges, 11 counseling contacts, and 7–11 automated reminders to use medication. Analyses identified subgroups of smokers highly adherent to nicotine patch use in both treatment conditions, and identified subgroups of A-OT participants highly adherent to mini-lozenges. Varied facets of nicotine dependence predicted adherence across treatment conditions 4 weeks post-quit and between 4- and 16-weeks post-quit in A-OT, with greater baseline dependence and greater smoking trigger exposure and reactivity predicting greater medication use. Greater quitting motivation and confidence, and believing that stop smoking medication was safe and easy to use were associated with greater adherence. Adherence was especially high in those who were more dependent and more exposed to smoking triggers. Quitting motivation and confidence predicted greater adherence, while negative beliefs about medication safety and acceptability predicted worse adherence. Results suggest that adherent use of medication may reflect a rational appraisal of the likelihood that one will need medication and will benefit from it.